Pliant Therapeutics Grows Slowly After IPO

From $16 drug maker of fibrotic disease Pliant Therapeutics rose to $22.85 on June 12. Volatility was not really significant to reach that price. Only slow growth rates accompanied NASDAQ: PLRX until Friday when quick recovery occurred due to Thursday’s major stocks’ crash.

In order to grow the share price, Pliant Therapeutics needs to keep its stockholders updated with valuable information. As of now, there is no news heard from its official site. Anytime Pliant Therapeutics might announce the process or completion of specific drugs that could change the world and make the revenue grow. Staying alert investors are always with big ears and visionary eyes to catch any opportunity that flies over the stock markets.

Asan Abdiev

CEO and Editor in Chief. Living in the era of dynamic tech change Asan decided to stay tuned in changes that make any person find comfort and adapt to new devices. Furthermore, gaming became his passion for spending leisure time with his close ones. Although, he has a degree in Business Administration (majoring Finance) writing for technology and as well as finance has been one of the precious aspects of his life